Cortex – Life Sciences Insights

11 Sep, 2024

Navigating EU and national regulatory scrutiny in so called “killer acquisitions”

By Alexandra Kamerling Darach Connolly Zoltan Marosi +2 more...

The implications of the recent Illumina/Grail Judgment Executive Summary In a landmark EU judgment, on 3 September 2024, the Court of...

10 Nov, 2022

By Bruna Rocha Juliana Marcondes

The SPAC structure not only enables the target companies to be listed in the United States’ public stock market through a simpler and...

02 Mar, 2021

By Moritz von Hesberg

The global outlook for M&A in the digital health and particularly the telehealth sector has never been brighter than today. Telehealth’s...

28 Feb, 2021

By Victoria Rhodes

At a time when the importance of the life sciences industry to our daily lives has never been clearer, the UK Government has been...

23 Oct, 2020

By Dr Kokularajah Paheenthararajah

This international report on "Digital Therapeutics - Evolution and entry into mainstream healthcare" was recently published jointly by...